Gene Biotherapeutics, Inc.
USD0.00
+0.00 (+9900.00%)
CEO
Christopher J. Reinhard
IPO Date
2000-05-03
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.00
Market Cap
$0.00B
Volume
0.01M
| 200,000 |
| $0.40 |
| 18 Mar 2021 | Jemapete Christopher J | 10 percent owner | P-Purchase | Acquired | 300,000 | $0.04 |
| 1 Mar 2021 | Jemapete Christopher J | 10 percent owner | Disposed | 0 | $0.00 |
| 27 Mar 2015 | HUTCHISON MURRAY H | director | J-Other | Acquired | 50,000 | $0.60 |
| 27 Mar 2015 | Leitch Andrew M | director | J-Other | Acquired | 50,000 | $0.60 |
| 4 Mar 2014 | HUTCHISON MURRAY H | director | J-Other | Acquired | 50,000 | $0.80 |
| 4 Mar 2014 | MULROY DENNIS | Chief Financial Officer | J-Other | Acquired | 50,000 | $0.80 |
| 4 Mar 2014 | Leitch Andrew M | director | J-Other | Acquired | 50,000 | $0.80 |